Marshall Wace’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-422,870
Closed -$4.21M 4024
2022
Q2
$4.21M Hold
422,870
0.01% 1470
2022
Q1
$4.19M Hold
422,870
0.01% 1502
2021
Q4
$4.16M Hold
422,870
0.01% 1501
2021
Q3
$4.16M Buy
+422,870
New +$4.13M 0.02% 1047

Marshall Wace's ISLE Position: Q3 2022 in Review

Marshall Wace sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q3 2022, closing a stake of 422,870 shares — an estimated $4.21M sold.

Marshall Wace first reported a position in ISLE in Q3 2021 and held it in 4 quarters. The position peaked at $4.21M in Q2 2022. 0 funds tracked by Wall St. Rank hold ISLE as of Q3 2022.

  • Marshall Wace reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q3 2022 after selling out during the quarter.
  • Marshall Wace sold 422,870 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2022, an estimated $4.21M.
  • Marshall Wace first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q3 2021 and held it in 4 quarters.
  • Marshall Wace's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $4.21M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2022.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.